ASTROCYTES AS THE SITE FOR BIOACTIVATION OF NEUROTOXINS

Citation
Da. Dimonte et al., ASTROCYTES AS THE SITE FOR BIOACTIVATION OF NEUROTOXINS, Neurotoxicology, 17(3-4), 1996, pp. 697-703
Citations number
40
Categorie Soggetti
Pharmacology & Pharmacy",Neurosciences
Journal title
ISSN journal
0161813X
Volume
17
Issue
3-4
Year of publication
1996
Pages
697 - 703
Database
ISI
SICI code
0161-813X(1996)17:3-4<697:AATSFB>2.0.ZU;2-9
Abstract
Evidence obtained from studies on the mechanisms of action of dopamine rgic neurotoxins suggests that glial cells may play an important role in neurodegenerative processes. A possible link between the function o f glial cells and nerve cell damage could relate to the ability of ast rocytes to convert innocuous compounds into toxic metabolites. Indeed, a mechanism of metabolic activation has been demonstrated in the MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) model of dopaminergic toxicity. The fully oxidized pyridinium metabolite (MPP+) is the ultim ate mediator of MPTP neurotoxicity and is apparently able to damage ne uronal cells after being formed within and released from astrocytes. D opaminergic neurons are particularly vulnerable to MPTP toxicity proba bly because of their ability to accumulate MPP+ and to retain it for a prolonged period of time. Two pathways of MPP+ formation have been id entified in astrocytes, one dependent upon the activity of monoamine o xidase (MAO) and the other related to the presence of transition metal s. Tetrahydroisoquinolines (TIQs) are neurotoxins similar to MPTP in c hemical structure as well as in their requirement for metabolic activa tion. Original data presented in this study do not support, however, a role of astrocytic MAO in the conversion of N-methyl-1,2,3,4-TIQ to t he corresponding quinolinium metabolite. (C) 1996 Inter Press, Inc.